A recent study conducted by UCLA Health suggests that a simple blood test could serve as an effective tool for determining an individual's susceptibility to stroke and cognitive decline later in life. Published in the journal Stroke, the study focused on measuring concentrations of inflammatory molecules in the blood to calculate a risk score for...
A recent study published in Neurology® Clinical Practice suggests a potential association between acid-reducing drugs and heightened risks of migraine and severe headaches.
A new study reveals a strong correlation between diet and brain health. Analyzing dietary data and health indicators from 181,990 UK Biobank participants, the study found that a balanced diet is crucial for cognitive function, mental well-being, and brain structure.
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford have analyzed data from participants in the UK Biobank to show that diabetes, traffic-related air pollution, and alcohol consumption are the most harmful factors out of 15 modifiable risk factors for dementia.
Prasinezumab, a monoclonal antibody targeting alpha-synuclein aggregation, shows promise in slowing motor deterioration in rapidly progressing Parkinson's disease (PD), according to an exploratory analysis from the phase 2 PASADENA clinical trial.
Green tea has become a popular beverage worldwide because of its health benefits, including antioxidant, antimicrobial, and cholesterol-lowering effects.
Flavonoid-rich foods like berries can enhance cognitive function and happiness across the lifespan, especially in healthy and cognitively impaired individuals.
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Researchers identified key risk factors and genetic influences impacting a specific brain network vulnerable to aging, schizophrenia, and Alzheimer's disease.
In a recent study published in the journal BMJ, a team of French researchers investigated the association between progestogen use and the risk of benign central nervous system tumors such as intracranial meningioma among women.
